Veeva Systems Logo
US9224751084
A1W5SA
VEEV

Veeva Systems

Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 274,55 € (+0,38 %). Medianen er 280,59 € (+2,59 %).

Køb
  29
Behold
  13
Sælg
  1

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Veeva Systems raises annual targets after strong quarter thanks to Vault CRM and AI agents

    Veeva Systems beat expectations in the second quarter: revenue rose 18% to $928 million, subscriptions increased 16%, and adjusted earnings per share were $2.35. Management raised the full-year forecast and now expects up to $3.687 billion in revenue and earnings per share of around $9.21. The Vault CRM solution and AI agents were cited as stock drivers, while Veeva continues to expand its market-leading position in the life‑sciences sector. » Mere på finanzen.net


  • Veeva deepens AI strategy at Citi Global TMT Conference 2026

    Veeva emphasized at the conference that about 98% of revenue still comes from the life sciences sector, commercial subscriptions recently showed roughly 13% year‑over‑year growth, and R&D growth has slowed to mid single‑digit to mid‑teens percentages. The newly positioned Falcon platform is intended to automate agent‑based end‑to‑end workflows, complemented by Vault AI for user‑centric productivity features; pricing for AI products will be transaction‑ and usage‑based to preserve software‑like margins. Veeva signals cautious but accelerated AI deployment, opportunistic acquisitions to speed the roadmap, and is launching Aspen as a standalone CRM initiative outside the core sector. » Mere på de.investing.com


  • Veeva Systems establishes itself as operating system of the pharmaceutical industry with a massive moat

    Veeva Systems offers cloud software exclusively for the life‑sciences sector and is used by more than 1,500 pharmaceutical, biotech, and medical‑technology companies for clinical trials, regulatory approval, quality, drug safety, and marketing. Products such as Vault CRM, Development Cloud, Quality Cloud, and Data Cloud are deeply embedded in regulated workflows, creating high switching costs and a strong moat. Veeva is targeting a market share of over 70% and sees AI features as extending this competitive advantage. » Mere på finanzen.net


  • Veeva exceeds expectations thanks to AI push

    Veeva reports better-than-expected revenue and earnings, driven by an AI strategy that CEO Peter Gassner called "the next big chapter." Its core product Vault CRM posted its strongest quarter and is in use at more than 180 customers, including twelve of the 20 largest biopharma companies. The development of agentic AI is also creating new product and growth opportunities. » Mere på finanzen.net


  • Veeva Systems beats Q2 expectations and raises full-year outlook

    Veeva Systems reported adjusted EPS of $2.35 for the quarter ended July 31 (expectation $2.22) and revenue of $928m (expectation $905.4m). Revenue from commercial subscriptions rose 13%, the company recorded its best CRM quarter and has more than 180 Vault-CRM customers live. Management raised the fiscal 2027 outlook, cited Falcon and other new products as growth drivers, and emphasized the shift to next‑gen R&D offerings. The stock rose about 9.4% in after‑hours trading to $268. » Mere på de.investing.com

I 2022 har Veeva Systems allerede udloddet 0,0149 € i udbytte. Den seneste udlodning fandt sted i februar 2022.

Virksomhedstal

I det seneste kvartal havde Veeva Systems en omsætning på 804,36 mio. € og et nettoresultat på 237,01 mio. €
(EUR) juli 2026
YoY
Omsætning 804,36 mio. 16,44 %
Bruttofortjeneste 603,25 mio. 16,05 %
Nettoresultat 237,01 mio. 35,16 %
EBITDA 312,4 mio. 29,54 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
44,78 mia. €
Antal aktier
161,91 mio.
Højeste/laveste i 52 uger
295,06 € - 134,00 €
Udbytte Nej
Beta
0,90
P/E (PE Ratio)
49,20
PEG (PEG Ratio)
1,99
K/I (PB Ratio)
6,67
P/S (PS Ratio)
14,31

Virksomhedsprofil

Veeva Systems Inc. leverer cloudbaseret software til life sciences-branchen i Nordamerika, Europa, Asien-Stillehavsområdet, Mellemøsten, Afrika og Latinamerika. Virksomheden tilbyder Veeva Commercial Cloud, en pakke af software-, data- og analyseløsninger, som omfatter Veeva customer relationship management (CRM) og Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud og MyVeeva for Patients; samt Veeva Vault, en cloudbaseret applikation til virksomhedens indholds- og datahåndtering til styring af kommercielle funktioner, herunder salg og markedsføring samt medicinsk indhold og kommunikation, samt forsknings- og udviklingsfunktioner, såsom klinisk, regulatorisk, kvalitets- og sikkerhedsmæssig håndtering. Virksomheden leverer også professionelle services og supportydelser inden for implementering og udrulningsplanlægning samt projektledelse; kravanalyse, løsningsdesign og konfiguration; styring af systemmiljøer og udrulningsydelser; ydelser, der fokuserer på at udvikle eller transformere forretnings- og driftsprocesser relateret til Veeva-løsninger; tekniske konsulentydelser vedrørende datamigrering og systemintegrationer; uddannelse i sine løsninger; og løbende managed services, som omfatter outsourcet systemadministration. Virksomheden var tidligere kendt som Verticals onDemand, Inc. og ændrede navn til Veeva Systems Inc. i april 2009. Veeva Systems Inc. blev stiftet i 2007 og har hovedkontor i Pleasanton, Californien.

Navn
Veeva Systems
CEO
Peter Gassner
Hjemsted Pleasanton, ca
USA
Websted
Sektor
Sundhed
Branche
Sundhedsteknologi
Børsnotering
06.08.2014
Medarbejdere 7.928

Tickersymboler

Børs Symbol
NYSE
VEEV
London Stock Exchange
0LO3.L
XETRA
VEE.DE
Frankfurt
VEE.F
Düsseldorf
VEE.DU
London
0LO3.L
SIX
VEE.SW
München
VEE.MU
Wien
VEEV.VI
Milan
1VEEV.MI
🍪

Parqet  bruger cookies. Læs mere